S Schulman Selected Research

S Schulman Research Topics

Disease

25	Hemorrhage 07/2021 - 03/2002
11	Venous Thromboembolism 01/2017 - 06/2000
7	Atrial Fibrillation 01/2017 - 07/2003
6	Thrombosis (Thrombus) 07/2021 - 01/2003
6	Stroke (Strokes) 01/2017 - 07/2003
6	Thromboembolism 10/2014 - 10/2008
6	Hemophilia A (Haemophilia) 03/2009 - 11/2001
5	Neoplasms (Cancer) 06/2015 - 06/2000
5	Venous Thrombosis (Deep-Vein Thrombosis) 08/2013 - 05/2000
3	Hematoma 10/2014 - 10/2008
3	von Willebrand Diseases (von Willebrand's Disease) 01/2004 - 12/2001
2	Thrombocytopenia (Thrombopenia) 01/2021 - 12/2011
2	Pulmonary Embolism 03/2016 - 07/2003
2	Hemophilia B (Haemophilia B) 01/2004 - 03/2003
1	COVID-19 07/2021
1	Critical Illness (Critically Ill) 07/2021
1	Lemierre Syndrome 01/2021
1	Pre-Eclampsia (Preeclampsia) 01/2021
1	Embolism (Embolus) 01/2017
1	Cardiac Arrhythmias (Arrythmia) 05/2015
1	Ischemic Stroke 05/2015
1	Pain (Aches) 12/2014
1	Necrosis 12/2011
1	Postthrombotic Syndrome 08/2010
1	Acute-Phase Reaction 05/2009
1	Factor VII Deficiency (Hypoproconvertinemia) 01/2009
1	Insulin Resistance 12/2008
1	Postoperative Hemorrhage 01/2007
1	Factor XI Deficiency (Hemophilia C) 05/2006
1	Hemorrhagic Disorders (Hemorrhagic Diathesis) 01/2006
1	Disease Susceptibility (Diathesis) 01/2006
1	Type 3 von Willebrand Disease 01/2004
1	Myocardial Infarction 07/2003
1	Renal Insufficiency (Renal Failure) 07/2003
1	Obesity 07/2003
1	Shock 07/2003
1	Wounds and Injuries (Trauma) 03/2003

Drug/Important Bio-Agent (IBA)

16	AnticoagulantsIBA 07/2021 - 06/2000
8	Warfarin (Coumadin)FDA LinkGeneric 05/2015 - 06/2000
7	Vitamin K FDA Link 10/2014 - 06/2000
3	Plasminogen Activator Inhibitor 1IBA 12/2008 - 01/2006
3	AntigensIBA 01/2006 - 11/2001
2	fibrin fragment D (D-dimer)IBA 10/2016 - 03/2016
2	Dabigatran FDA Link 01/2016 - 03/2015
2	Heparin (Liquaemin)FDA LinkGeneric 12/2011 - 10/2008
2	Factor VIII (Coagulation Factor VIII)IBA 05/2009 - 09/2004
2	Protein CIBA 03/2009 - 06/2000
2	Plasminogen InactivatorsIBA 12/2008 - 01/2007
2	Thrombin FDA Link 01/2004 - 11/2001
2	Carboxypeptidase B2 (Thrombin Activatable Fibrinolysis Inhibitor)IBA 01/2004 - 11/2001
2	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 07/2003 - 01/2003
1	Transaminases (Aminotransferases)IBA 01/2021
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2021
1	Antiphospholipid AntibodiesIBA 09/2015
1	Pharmaceutical PreparationsIBA 01/2014
1	RivaroxabanIBA 08/2013
1	Serotonin (5 Hydroxytryptamine)IBA 12/2011
1	Fondaparinux (Arixtra)FDA Link 12/2011
1	Platelet Factor 4IBA 12/2011
1	AntibodiesIBA 12/2011
1	GlycosaminoglycansIBA 08/2010
1	Biosimilar PharmaceuticalsIBA 07/2009
1	Lupus Coagulation Inhibitor (Lupus Anticoagulant)IBA 05/2009
1	Factor VII (Proconvertin)IBA 01/2009
1	Insulin (Novolin)FDA Link 12/2008
1	coumarinIBA 10/2008
1	Hemoglobins (Hemoglobin)IBA 01/2007
1	recombinant FVIIa (rFVIIa)FDA Link 05/2006
1	von Willebrand factor drug combination factor VIIIIBA 01/2006
1	Fibrinogen (Factor I)FDA Link 01/2006
1	Tissue Plasminogen Activator (Alteplase)FDA Link 01/2006
1	recombinant factor VIII SQIBA 09/2004
1	EnzymesIBA 01/2004
1	Fibrinolysin FDA Link 01/2004
1	Tranexamic Acid (AMCA)FDA Link 07/2003
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 07/2003
1	prothrombin complex concentrates (PPSB)IBA 03/2003
1	Factor IX (Coagulation Factor IX)FDA LinkGeneric 03/2003
1	Monoclonal AntibodiesIBA 03/2003
1	MononineIBA 03/2003
1	ximelagatran (Exanta)IBA 01/2003
1	Dalteparin (Dalteparin Sodium)FDA Link 01/2003
1	AntithrombinsIBA 01/2003
1	Interferon-alpha (Interferon Alfa)IBA 03/2002
1	Ribavirin (Virazole)FDA LinkGeneric 03/2002
1	InterferonsIBA 03/2002

Therapy/Procedure

16	Therapeutics 10/2016 - 05/2000
1	Orthopedic Procedures 01/2017
1	Duration of Therapy 09/2015
1	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 05/2015
1	Compression Stockings 12/2014
1	Surgical Amputation (Amputations) 12/2011
1	Vascular Surgical Procedures 12/2011
1	Stents 08/2010
1	Catheters 08/2010
1	Transurethral Resection of Prostate (TURP) 01/2007
1	Operative Surgical Procedures 10/2004
1	Erythrocyte Transfusion 09/2004
1	Thrombolytic Therapy 07/2003
1	Intravenous Infusions 03/2003